| Literature DB >> 22860155 |
Abstract
On January 21, 2011, the U.S. Food and Drug Administration approved Viibryd, a new selective serotonin reuptake inhibitor (SSRI), to treat major depressive disorder in adults developed by Clinical Data, Inc.Entities:
Keywords: Depression; SSRI; antidepressant; major depressive disorder
Mesh：
Substances：
Year: 2011 PMID： 22860155 PMCID： PMC3369713 DOI： 10.1021/cn200084v
Source DB: PubMed Journal: ACS Chem Neurosci ISSN： 1948-7193 Impact factor: 4.418